Drawing for SPAGYRIA

USPTO serial 78123997

SPAGYRIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HARDY LUDLOW, TARAH KIM
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SPAGYRIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005US 006 018 044 046 051 052. G & S: HERBAL, DIETARY AND NUTRITIONAL SUPPLEMENTS USED IN EXTRACTS, TINCTURES, ESSENCES, VINEGARS, GLYCERITES, HERBAL TEAS, DRUGS, PHARMACEUTICAL PREPARATIONS AND NATURAL HEALING PHARMACEUTICAL PREPARATIONS FOR MEDICINAL PURPOSES MADE ACCORDING TO THE ALCHEMICAL FORMULAS AND RECIPIES OF SPAGYRIA NAMELY, PHARMACEUTICAL PREPARATION FOR TREATING AILMENTS OF THE HEART, MUSCLES, NERVES, EYES; PHARMACEUTICAL PREPARATION FOR TREATING GOITER; EXPECTORANTS; SEDATIVES; ASTRINGENT FOR MEDICAL USE; AND FOR THE TREATMENT OF ULCERS AND TUMORS, INFLAMMATIONS, INFECTIONS, FEVER, AND ARTICULAR RHEUMATISM, CENTRAL NERVOUS SYSTEM PROBLEMS, SLEEPING TROUBLES, HEART AND CIRCULATORY DISORDERS, HEART DISEASE, SKIN DISEASES INCLUDING FISTULA, FURUNCLE, ACNE, ECZEMA, AND SCROFULA, STRENGTHENING THE IMMUNE SYSTEM, DISEASES OF THE LIVER AND GALL-BLADDER, DISEASE OF THE GLAND SYSTEM, ESPECIALLY THE LYMPHATIC SYSTEM, GYNECOLOGICAL DISORDERS, DYSMENORRHOEA, MUSCLE CRAMPS, SEIZURES, HYPERMENORRHEOA, DIARRHEA AND DYSENTERY, EYE DISEASES, PSYCHIC-MENTAL CONDITIONS OF TENSION, INFLAMMATION OF THE LUNGS AND BRONCHIAL ASTHMA, DISEASE OF THE RENAL AND URINARY BLADDER SYSTEM, LOW BLOOD PRESSURE, LACK OF APPETITE, DEPRESSIONS, KIDNEY STONES, BLADDER STONES, AND GOUT, ACUTE, NON-INFLAMMABLE STOMACH AND BOWEL TROUBLES, METEORISM, AND ROEMHELD SYNDROME, CHRONIC INFLAMMABLE STOMACH AND BOWEL TROUBLES, STANCHING BLOOD, BLEEDING, AND WOUNDS, ACUTE AND CHRONIC STOMACH AND BOWEL CATARRH, DEGENERATING SKIN TROUBLES, HEADACHES, TRIGEMINUS NEURALGIA, SCIATICA, TREMBLING, AND WEAKNESS OF THE LIMBS, GLANDULAR DISORDERS, LUNG DISEASE, RHEUMATIC TROUBLES.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 16, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 11, 2002DOCKASSIGNED TO EXAMINER—
Aug 25, 2002GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance